Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Journal.
Press releases published on August 1, 2025
Sustainable Handmade Boho Floor Lamps Now Available at Home and Soul Furniture
EIN Presswire
·
August 1, 2025
Handmade floor lamps from Home and Soul Furniture blend modern, boho style with eco-friendly craftsmanship, providing sustainable lighting for any space DUBAI, DUBAI, UNITED ARAB EMIRATES, August 1, 2025 /EINPresswire.com/ -- Home and Soul Furniture …
Energy America Expands Global Power Development Footprint with Strategic Focus on Africa's Hybrid Energy Infrastructure
EIN Presswire
·
August 1, 2025
SAN FRANCISCO, CA, UNITED STATES, July 31, 2025 /EINPresswire.com/ -- Energy America (EA), a U.S.-based renewable energy powerhouse, announces its expanded commitment to hybrid power plant development across Africa through robust partnerships with both …
Taseko to Release Second Quarter 2025 Results
GlobeNewswire
·
August 1, 2025
VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (the "Company") will release its second quarter 2025 financial results after market close on Wednesday, August 6, 2025. The Company …
Allogene Therapeutics Moves Forward with Standard Fludarabine and Cyclophosphamide (FC) Lymphodepletion Regimen in the ALPHA3 Trial for Cemacabtagene Ansegedleucel (Cema-Cel) in First-Line Consolidation for Large B-Cell Lymphoma
GlobeNewswire
·
August 1, 2025
Lymphodepletion Regimen Selection Made in Conjunction with the ALPHA3 Data and Safety Monitoring Board (DSMB) and Steering Committee, and in Consultation with the FDA Following an ALLO-647-Related Death in the FCA (FC plus ALLO-647) Lymphodepletion Arm …
Orchestra BioMed Announces Pricing of $40 Million Public Offering
GlobeNewswire
·
August 1, 2025
NEW HOPE, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced …
Nexxen Announces July 2025 Share Repurchase Program Summary
GlobeNewswire
·
August 1, 2025
NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Nexxen International Ltd. (NASDAQ: NEXN) (“Nexxen” or the “Company”), a global, flexible advertising technology platform with deep expertise in data and advanced TV, today announced that during July 2025 the …
Medicenna Therapeutics Reports First Quarter Fiscal 2026 Financial Results and Operational Highlights
GlobeNewswire
·
August 1, 2025
Updated cash guidance provides runway into at least the middle of calendar 2026 Company remains encouraged by MDNA11 clinical results presented to-date, demonstrating best-in-class potential of our IL-2 superkine by exceeding ORR benchmarks demonstrated …
Oculis Upsized Loan Facility to Access up to CHF 100 million
GlobeNewswire
·
August 1, 2025
ZUG, Switzerland, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet …
Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement
GlobeNewswire
·
August 1, 2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) further to its …
Silexion Therapeutics Announces Exercise of Warrants for $1.8 Million Gross Proceeds
GlobeNewswire
·
August 1, 2025
Cayman Islands, July 31, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech company developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced …